VF
IART icon

Virtu Financial’s Integra LifeSciences IART Stock Holding History

Virtu Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,015
Closed -$124K – 1933
2025
Q4 		$124K Buy
+10,015
New +$133K ﹤0.01% 1157
2025
Q3 		– Sell
-15,840
Closed -$194K – 1737
2025
Q2 		$194K Buy
+15,840
New +$230K 0.01% 926
2022
Q3 		– Sell
-6,722
Closed -$363K – 1930
2022
Q2 		$363K Buy
+6,722
New +$404K 0.03% 496
2021
Q1 		– Sell
-10,600
Closed -$688K – 1792
2020
Q4 		$688K Buy
+10,600
New +$570K 0.07% 341
2018
Q3 		– Sell
-6,881
Closed -$443K – 1832
2018
Q2 		$443K Buy
+6,881
New +$426K 0.03% 876
2018
Q1 		– Sell
-7,895
Closed -$378K – 2233
2017
Q4 		$378K Buy
+7,895
New +$386K 0.02% 1067

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virtu Financial's IART Position: Q1 2026 in Review

Virtu Financial sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 10,015 shares — an estimated $124K sold.

Virtu Financial first reported a position in IART in Q4 2017 and held it in 6 quarters. The position peaked at $688K in Q4 2020. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Virtu Financial reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 10,015 Integra LifeSciences shares in Q1 2026, an estimated $124K.
  • Virtu Financial first reported a position in Integra LifeSciences in Q4 2017 and held it in 6 quarters.
  • Virtu Financial's Integra LifeSciences position peaked at $688K in Q4 2020.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.